American Journal of Kidney Diseases
Volume 49, Issue 1 , Pages 109-117, January 2007

The Effect of Mesna on Plasma Total Homocysteine Concentration in Hemodialysis Patients

Departments of Medicine and Physiology and Pharmacology, University of Western Ontario; Lawson Health Research Institute; and Robarts Research Institute, London, Ontario, Canada.

Received 31 July 2006; accepted 2 October 2006. published online 12 December 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2006.10.002 on November 28, 2006.Support: A grant from Lawson Health Research Institute funded this study. Potential conflicts of interest: The authors have applied for a patent for the use of mesna in patients with end-stage renal disease.

PII: S0272-6386(06)01511-3

doi:10.1053/j.ajkd.2006.10.002

American Journal of Kidney Diseases
Volume 49, Issue 1 , Pages 109-117, January 2007

Article Tools

* Image Usage & Resolution